Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 17 de 17
Filter
1.
Fr J Urol ; 34(4): 102607, 2024 Mar 15.
Article in English | MEDLINE | ID: mdl-38431081

ABSTRACT

PURPOSE: The aim of this study was to investigate the compliance with follow-up in patients receiving adjuvant chemotherapy (ACT) for testicular cancer at two academic hospitals. MATERIALS AND METHODS: The study analyzed 104 patients with testicular tumors who had undergone surgery at least a year before and received ACT between March 2017 to March 2022. The mean follow-up was 29.2±16.2 (12-73) months. Patients were classified as fully compliant (100% compliance), moderately compliant (50-99%), poorly compliant (1-49%), and non-compliant (no attendance) according to their compliance with the follow-up schedule. RESULTS: At the end of the first year, 76% of patients were fully compliant. By the end of the second year, this number dropped to 50%. Furthermore, 25% of patients were identified as non-compliant in the second year and only 4.3% in the third year. When comparing patients who were compliant and non-compliant at first- and second-year follow-up, no statistically significant difference was found according to age, tumor size, disease stage, or ACT regimen (P=0.938, P=0.784, P=0.867, and P=0.282, respectively). CONCLUSION: This study showed that full compliance with follow-up gradually decreased over the years and that the factors examined were not able to predict this decrease. Prospective studies can help design individualized education and follow-up programs, considering each patient's tumor stage.

2.
Curr Med Imaging ; 20(1): e15734056301569, 2024.
Article in English | MEDLINE | ID: mdl-38544394

ABSTRACT

OBJECTIVE: This study aims to investigate the association of preoperative body composition parameters, measured by computed tomography in patients undergoing surgery for renal cell carcinoma, with its stage and to survey the relationship with postoperative hospitalization duration and survival. METHODS: Demographic data, pathology results, cancer stages, and hospitalization duration of 104 patients undergoing surgery at the urology clinic due to renal cell carcinoma between 2019 and 2023 were analyzed retrospectively. On computed tomography scans acquired during diagnosis, visceral adipose tissue, subcutaneous adipose tissue, total adipose tissue, and skeletal muscle area were measured. The ratios of body composition parameters were computed. RESULTS: When the correlation between survival time and body composition in deceased patients was analysed, a moderate but significant correlation was observed between skeletal muscle area value and total adipose tissue / skeletal muscle area ratio (r=0.630, p=0.001; r=0.598, p=0.002). A significant and strong correlation was observed between total adipose tissue value and survival (r=0.704, p<0.001). Subcutaneous adipose tissue / skeletal muscle area was found to be an independent risk factor associated with mortality, and a ratio of 0.98 or less increased the mortality risk approximately 16-fold. CONCLUSION: The relationship between body composition parameters measured by computed tomography, which can be easily evaluated pre-treatment, and mortality, postoperative recovery and length of hospital stay can be evaluated, giving clinicians an idea about the potential difficulties that patients may encounter during the treatment process. For this purpose, the subcutaneous adipose tissue / skeletal muscle area ratio is the most helpful parameter that can be used.

.


Subject(s)
Body Composition , Carcinoma, Renal Cell , Kidney Neoplasms , Neoplasm Staging , Tomography, X-Ray Computed , Humans , Male , Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/mortality , Carcinoma, Renal Cell/surgery , Female , Tomography, X-Ray Computed/methods , Middle Aged , Kidney Neoplasms/diagnostic imaging , Kidney Neoplasms/mortality , Retrospective Studies , Prognosis , Aged , Muscle, Skeletal/diagnostic imaging , Adult , Adipose Tissue/diagnostic imaging , Aged, 80 and over , Subcutaneous Fat/diagnostic imaging , Length of Stay
3.
Urol Res Pract ; 49(4): 225-232, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37877823

ABSTRACT

OBJECTIVE: The aim of this study is to evaluate current urologic practice regarding the management of priapism in Turkey and compare with international guidelines. METHODS: Urologists and urology residents were invited to an online survey consisting of 30 multiple-choice questions on priapism-related clinical practices that were consid- ered most important and relevant to practices by using Google Forms. RESULTS: Total number of responses was 340. Respondents reported that they recorded a detailed patient's medical history and physical examination findings (n = 340, 100%) and laboratory testing, which includes corporal blood gas analysis (n=323, 95%). Participants announced that they performed Doppler ultrasound for 1/4 cases (n = 106, 31%), but 22% of the participants (n=75) replied that they performed in >75% of cases. Participants (n=311, 91%) responded that the first-line treatment of ischemic priapism is decompression of the corpus cavernosum. Moreover, most respondents (n = 320, 94%) stated that sympathomimetic injection drugs should be applied as the second step. About three-quarters of respondents (n = 247, 73%) indicated adrenaline as their drug of choice. Phosphodiesterase type 5 inhibitors seems to be the most pre- ferred drug for stuttering priapism (n=141, 41%). Participants (n=284, 84%) replied that corpora-glanular shunts should be preferred as the first. A large number of par- ticipants (n = 239, 70%) declared that magnetic resonance imaging can be performed in cases with delayed (>24 hours) priapism to diagnose corporal necrosis. Most of the participants (84%) responded that penile prosthesis should be preferred to shunts in cases with delayed (>48 hours) priapism. CONCLUSION: It would be appropriate to improve the training offered by professional associations and to give more training time to the management of priapism during residency.

4.
Ulus Travma Acil Cerrahi Derg ; 29(9): 1032-1038, 2023 Sep.
Article in English | MEDLINE | ID: mdl-37681729

ABSTRACT

BACKGROUND: In this study, we aimed to determine the most appropriate antimicrobial agents for prophylactic antibiotic use during emergency and elective transurethral procedures. METHODS: The study was conducted in five hospitals located in five different geographical regions of Türkiye. The microorganism cultured in urine before emergency and elective transurethral procedures in these centers between March 2021 and March 2022 were reviewed retrospectively from the hospital records. Demographic data (age and gender) of the patients, comorbid disorders, previous urological procedures, anomalies of the urogenital tract, use of urethral catheters (permanent or clean intermittent catheterization), cultured microorganisms, and antibiotic susceptibilities were noted. The patients hospitalized or had antibiotics for any reason in the previous 1 month were excluded from the study. RESULTS: A total of 1450 patients, 742 men (51.2%) and 708 women (48.8%), were included in the study. The mean age of the patients was 55.3±19.36 (1-98) years. Diabetes mellitus was evident in 271 (18.7%) patients. The five most common microorgan-isms cultured in urine, in order of frequency, were: ESBL (-) Escherichia coli in 418 (28.8%), ESBL (+) E. coli in 309 (21.3%), Klebsiella pneumonia in 183 (12.6%), Enterococcus faecalis in 124 (8.6%), and Pseudomonas aeruginosa in 89 (6.1%). The susceptibility rates to antimicrobial agents recommended for prophylaxis by the American Urology Association and the European Association of Urology guidelines were found as follows: cefepime 87.1%, ampicillin+sulbactam 84%, TMP-SMX 71.6%, amoxicillin+clavulanate 63.5%, cefoxitin 59%, ceftazidime 58.6%, cefuroxime 43.5%, ceftriaxone 43%, and cefixime 38.4%. CONCLUSION: We found that currently recommended antimicrobials provide poor coverage for the most common pathogens isolated. Urologists should consider patient-based antibiotic prophylaxis in endoscopic urethral procedures, follow appropriate proto-cols, and consider local antibiotic resistance.


Subject(s)
Anti-Infective Agents , Escherichia coli , Male , Humans , Female , Adult , Middle Aged , Aged , Retrospective Studies , Anti-Bacterial Agents/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination
5.
Sex Med ; 11(3): qfad042, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37529683

ABSTRACT

Background: Increased carotid artery intima-media thickness (CIMT) has been shown to be associated with erectile dysfunction (ED), but studies evaluating the efficacy of CIMT in predicting drug response are lacking in the literature. Aim: We aimed to evaluate the efficacy of CIMT in predicting the response to phosphodiesterase-5 inhibitors (PDE5-I). Methods: A total of 274 subjects were divided into two groups: ED patients (n = 150) and controls (n = 124). The patients in the ED group were further divided into the subgroups of severe, moderate, mild-moderate, and mild ED. Blood tests, carotid ultrasonography, and the International Index of Erectile Function-5 (IIEF-5) diagnostic tool were applied to all subjects. Tadalafil was administered to each patient. The patients were re-evaluated using the IIEF-5 questionnaire after 2 months of treatment. According to their response to medication, the patients were evaluated as responders or nonresponders. Outcomes: Increased CIMT was significantly associated with the failure of PDE5-I therapy, especially in patients with moderate/mild-moderate ED. Results: Fasting blood glucose, body mass index, and CIMT were significantly higher in the ED group compared to the control group (P = .021, P = .006, and P < .001, respectively). The IIEF-5 score was significantly lower in the ED group (P < .001). CIMT was significantly correlated with the IIEF-5 score. When the total patient group was evaluated, the CIMT value of the responders was significantly lower than that of the nonresponders (P = .001). CIMT was significantly higher among the nonresponders with moderate/mild-moderate ED compared to the responders (P = .004 and .008, respectively), while there was no significant difference in CIMT between the responders and nonresponders with severe or mild ED. A receiver operating characteristic (ROC) analysis of CIMT was performed for discrimination between nonresponders and responders with moderate/mild-moderate ED. The area under the ROC curve was 0.801 (0.682-0.921) (P = .001), and the cutoff value was determined to be 0.825 mm, at which CIMT predicted the response to treatment with 65% sensitivity and 89% specificity. Clinical Implications: Using a validated CIMT cutoff value can help the physician inform the patient about the possibility of drug failure and avoid attempting second-line therapy too soon. Strengths and Limitations: There are three main limitations to our study. First, the number of participants was low. Second, ultrasound is a relatively subjective method, and third, all measurements were made by the same radiologist. Conclusion: CIMT can be used as a predictor of response to PDE5-I therapies in patients with moderate/mild-moderate ED.

6.
Investig Clin Urol ; 64(4): 404-411, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37417566

ABSTRACT

PURPOSE: In this study, we aimed to evaluate the clinical utility of the neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), lymphocyte/monocyte ratio (LMR), and monocyte/high-density lipoprotein cholesterol ratio (MHR) in predicting response to a phosphodiesterase type 5 inhibitor (PDE5i) when used as the first-line medical treatment of erectile dysfunction (ED). MATERIALS AND METHODS: This study prospectively included 185 patients who were diagnosed with ED and started PDE5i treatment. After PDE5i treatment, 107 (57.8%) patients with an International Index of Erectile Function-5 (IIEF-5) score below 22 were assigned to Group 1, and 78 (42.2%) patients with an IIEF-5 score of 22 or above were assigned to Group 2. The outcome measures of the study were demographic characteristics and inflammation markers between the groups. RESULTS: The mean IIEF-5 change after PDE5i treatment was 6.1±4.2 points in Group 1 and 11.5±3.2 points in Group 2 (p=0.001). The mean age was 54.6±9.2 years in Group 1 and 47.8±10.3 years in Group 2 (p<0.001), and the median fasting blood glucose values of Groups 1 and 2 were 105 (36) mg/dL and 97 (23) mg/dL, respectively (p=0.010). The LMR and MHR values were 2.39±0.23 and 13.8±7, respectively, for Group 1, and 2.03±0.22 and 17±6.6, respectively, for Group 2 (p=0.044 and p=0.002, respectively). On multivariable analysis, younger age and increased MHR were independent predictors of benefit from PDE5i treatment. CONCLUSIONS: This study showed that only MHR as an inflammatory biomarker was an independent predictor for response to PDE5i in the treatment of ED. Also, several factors were predictive of treatment failure.


Subject(s)
Erectile Dysfunction , Male , Humans , Middle Aged , Erectile Dysfunction/drug therapy , Phosphodiesterase 5 Inhibitors/therapeutic use , Penile Erection , Treatment Outcome , Biomarkers
7.
World J Urol ; 41(8): 2243-2248, 2023 Aug.
Article in English | MEDLINE | ID: mdl-37389654

ABSTRACT

PURPOSE: Since some urological diseases are age-dependent, these patients are admitted to urology wards for treatment more frequently as an inevitable result of aging. In this study, the urological hospitalization reasons and outcomes patients in octogenarian and nonagenarian age groups were evaluated in comparison with younger adult patients. METHODS: After examining a total of 5615 urology ward admissions of individuals aged 18-99 years, we included 443 (7.7%) patients aged 80-89 years in the octogenarian group and 32 (0.6%) patients in the nonagenarian group. Ten percent of the remaining 5150 adults were randomly selected to form the control group. RESULTS: The mean ages of the control, octogenarian, and nonagenarian groups were 55.4 ± 16, 83.3 ± 2.6, and 91.9 ± 1.8 years, respectively. The most frequent reasons for the hospitalization were a history of or active bladder tumors in the octogenarian and nonagenarian groups [117 (38.5%) and 3 (21.4%), respectively]. The incidences of any complication in the control, octogenarian, and nonagenarian groups were 61 (12.2%), 63 (15.7%), and 12 (42.9%), respectively. Mortality was seen in five (1%) patients in the control group, 11 (2.5%) in the octogenarians, and five (15.6%) in the nonagenarians. The complication and mortality rates of the nonagenarian group were statistically significantly higher than the remaining two groups (p < 0.001). CONCLUSION: Due to additional problems that increase with aging, the urology hospitalizations of octogenarian and nonagenarian patients result in more complications. Mortality rates also increase with age. It is aimed to contribute to the literature by revealing the needs and outcomes of octogenarian and nonagenarian patients in the urology clinic.


Subject(s)
Nonagenarians , Octogenarians , Aged, 80 and over , Adult , Humans , Hospitalization , Length of Stay , Incidence , Treatment Outcome , Retrospective Studies , Age Factors
8.
Prostate Int ; 10(4): 218-223, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36570650

ABSTRACT

Purpose: Questionnaire forms (QFs) are used in the evaluation of all patients presenting with lower urinary tract symptoms (LUTSs). Our study aims to investigate the compatibility of the three QFs with each other and to investigate the relationship between education level and complete completion of these forms. Materials and methods: A total of 224 patients between February 2018 and February 2019 were included. The patients were divided into 3 groups as primary, intermediate, and advanced according to their education level and the patients who gave incomplete answers to the questions were determined. Results: The mean age of the patients was 61.0 ± 7.57(45-85), International Prostate Symptom Score (IPSS) value was 16.2 ± 8.3(1-35), the international incontinence form-male lower urinary tract symptoms (ICIQ-MLUTS) value was 16.5 ± 7.9(0-38), the visual prostate symptom score (VPSS) value was 9.9 ± 3.0(3-16). There was a significant correlation between the three QFs (P < 0.05). The correlation between IPSS and ICIQ-MLUTS was strong (r = 0.745). The incomplete response rate was 32.1% (n = 72) in ICIQ-MLUTS, 16.5% (n = 37) in VPSS, and 10.7% (n = 24) in IPSS (P < 0.05). The incomplete response rate was not affected by education. The rate of patients who could be questioned with ICIQ-MLUTS but not with the other two QFs varied between 12.9% and 85.2%, depending on the symptoms. Conclusions: Each QF has its advantages and disadvantages. The strong correlation between IPSS and ICIQ-MLUTS found in our study indicates that these tools can be used interchangeably in daily clinical practice. ICIQ-MLUTS can evaluate symptoms that are not present in other QFs. In the evaluation of illiterate patients, VPSS should be used without any alternative.

9.
J Pediatr Urol ; 18(4): 515.e1-515.e6, 2022 08.
Article in English | MEDLINE | ID: mdl-35659826

ABSTRACT

INTRODUCTION AND OBJECTIVE: There are thousands of patient information videos published on YouTube, the most watched video sharing platform; however, most of these videos contain incomplete or incorrect information. Interestingly, some videos with incomplete or incorrect information have a higher view rate. This study aimed to evaluate the quality of patient information videos on 'undescended testis' published on YouTube. MATERIAL AND METHOD: A search was conducted on YouTube using the keywords 'undescended testis' and 'cryptorchidism', and a total of 373 videos were found. Among these, 122 patient information videos presented in the English language were examined. Four different scoring systems were used to evaluate the quality of the videos: Patient Education Materials Assessment Tool for Audiovisual Materials, Global Quality Score, Journal of American Medical Association score, and modified DISCERN scoring system. Whether the videos contained accurate and sufficient information was evaluated using a scoring system developed based on the patient information booklet prepared by the European Association of Urology (EAU) on undescended testis. RESULTS: The median duration (sec), number of views and number of likes of the videos were 269 (11-2484), 589 (6-1.563561) and 7 (0-4.200), respectively. According to the EAU-patient information scoring (EAU-PIS), while 32 (26.2%) of the total 122 videos contained a good level of informativeness (score: 8-10), the view rate of these videos was only 4.1% among all videos. When the top 10 most watched videos were evaluated, their mean EAU-PIS was 5.9 ± 2.81, and these videos contained a moderate level of informativeness. On the positive side, 90% of all the videos recommended surgery as a treatment option. DISCUSSION: Although YouTube is a widely used video-sharing platform, it is also a website where people or institutions can easily upload non-standardized videos due to the absence of regulations. Therefore, although it is an easily accessible source of information, it has many gaps in terms of reliability. As shown in our study, the rate of videos with accurate information was very low. It would be beneficial for viewers to be aware of this and accept YouTube as a source where they can have a general idea about a subject in which they are interested rather than using it as a reference information site. In future, YouTube can become a reference source in the medical field, especially with the standardization of medical videos through the collaboration of various organizations.


Subject(s)
Social Media , Male , Humans , Information Dissemination , Video Recording , Reproducibility of Results , Testis
10.
Surg Endosc ; 35(3): 1101-1107, 2021 03.
Article in English | MEDLINE | ID: mdl-32152673

ABSTRACT

BACKGROUND: Different techniques for laparoscopic adrenalectomy have been proposed with the lateral transperitoneal approach and posterior retroperitoneal approach being the two more frequently minimally invasive surgeries in most of the clinics. There are no sufficient studies in which the results of lateral transperitoneal and posterior retroperitoneal approaches in synchronous bilateral laparoscopic adrenalectomy have been compared. In the current study, we aimed to report our multicenter results of the lateral transperitoneal and posterior retroperitoneal synchronous bilateral laparoscopic adrenalectomy experience in patients who had different bilateral adrenal pathologies and to compare the outcomes of these two different operative procedures. METHODS: Between 2012 and 2018, a total of 52 patients with a mean age of 43.5 years underwent simultaneous bilateral laparoscopic adrenalectomy at 6 different centers. Twenty-seven and 25 patients underwent bilateral lateral transperitoneal and posterior retroperitoneal laparoscopic adrenalectomy, respectively. Patients' age, gender, body max index, operative indications, mass size, operation time, blood loss, length of hospitalization, intraoperative and postoperative complications and pathology reports were analyzed. RESULTS: Synchronous bilateral transperitoneal group was younger than synchronous posterior retroperitoneal group (37 years vs. 50.4 years.) (p: 0.001). Posterior retroperitoneal group had significantly decreased operating time and less blood loss than transperitoneal group. No significant difference was found with regard to postoperative hospital stay, perioperative and postoperative complications between two groups. Majority of the histopathological results were adrenal hyperplasia associated with Cushing's disease (61.5%). Less frequent pathological results were adrenal adenoma and pheochromocytoma (15.4% and 13.5%, respectively). During the follow-up period, no recurrence or disease-related mortality was observed in the patients. CONCLUSION: Our results shows that shorter operative time and less bleeding can be achieved with posterior retroperitoneal approach in synchronous bilateral laparoscopic adrenalectomy. In our series, intraoperative and postoperative complication rates were similar between both surgical approaches.


Subject(s)
Adrenal Gland Neoplasms/surgery , Adrenalectomy/methods , Laparoscopy/methods , Postoperative Complications/etiology , Adolescent , Adrenal Gland Neoplasms/pathology , Adrenalectomy/adverse effects , Adult , Aged , Child , Female , Humans , Laparoscopy/adverse effects , Length of Stay , Male , Middle Aged , Operative Time , Pheochromocytoma/pathology , Pheochromocytoma/surgery , Pituitary ACTH Hypersecretion/surgery , Retroperitoneal Space/surgery , Young Adult
11.
J Pediatr Urol ; 16(5): 645.e1-645.e7, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32826183

ABSTRACT

BACKGROUND: Primary monosymptomatic nocturnal enuresis (MNE) is a common pediatric condition and there are two firstline, evidence-based treatments available; desmopressin and the enuresis alarm. Although there are many studies comparing enuresis alarm and desmopressin treatments in the literature, most were conducted using old formulations of desmopressin. OBJECTIVE: To compare the efficacy of desmopressin MELT formulation and enuresis alarm therapy in patients with MNE. STUDY DESIGN: A total of 130 patients who had primary MNE were included in the study. The patients were divided into two groups using simple randomization; desmopressin MELT (Group 1, n = 66) and enuresis alarm (Group 2, n = 64). The patients were invited for a follow-up visit at the fourth, 12th and 24th weeks of treatment. Treatment response and compliance were evaluated using bed-wetting diary and ICSS criteria. RESULTS: The mean age of the patients Group 1 and 2 was 11.2 + 3.3 and 10.2 + 3.4 years, respectively (p = 0.104). Complete response rate was similar at 4th week (53% vs. 37.3%, p = 0.162) and at 12th week (68.4% vs. 68.2%, p = 0.257). The relapse rate was significantly higher in the desmopressin MELT group than in the enuresis alarm group (48.9% vs 20.5%, p = 0.007). At the end of the study ten patients were excluded from the study because of loss to follow-up and/or side effects. The overall complete response rate was significantly higher in the enuresis alarm group than in the desmopressin MELT group at the end of the study (41.3% vs 64.9%, p = 0.035). When the intention to treat analysis population was considered, similarly the complete response rate was significantly higher in the enuresis alarm group than in the desmopressin MELT group (40.9% vs 64.1%, p = 0.027). DISCUSSION: With regard to the management of children with MNE, our study revealed that desmopressin MELT and enuresis alarm both have high efficacy rates in primary MNE treatment both at 4th and 12th week. However, overall complete response rate was better in enuresis alarm treatment at 24th week. In addition, enuresis alarm treatment also presents as a more favorable relapse rate. CONCLUSIONS: Enuresis alarm presented a more permanent treatment response and a lower relapse rate than desmopressin MELT formulation.


Subject(s)
Clinical Alarms , Enuresis , Nocturnal Enuresis , Adolescent , Child , Deamino Arginine Vasopressin , Humans , Nocturnal Enuresis/drug therapy , Recurrence
12.
Turk J Urol ; 42(2): 70-3, 2016 Jun.
Article in English | MEDLINE | ID: mdl-27274890

ABSTRACT

OBJECTIVE: To evaluate our complications in renal and adrenal transperitoneal laparoscopic surgeries with Clavien-Dindo classification. MATERIAL AND METHODS: Two hundred and eight patients to whom renal and adrenal laparoscopic surgeries were performed between January 2008 and June 2015 were included the study. One hundred and twenty one (58.2%) patients were female and 87 (41.8%) of them were male. Laparoscopic procedures were performed as radical nephrectomy (n=49; 23.6%), simple nephrectomy (n=56; 26.9%), and partial nephrectomy (n=7; 3.4%), renal cyst decortication (n=27; 13%), pyelopasty (n=14; 6.7%) and adrenalectomy (n=55; 26.4%). Complications were classified according to Clavien-Dindo classification. RESULTS: The mean age of the patients was 48.01±14.9 years. The mean duration of hospital stay was 3.5±1.9 days. According to European Scoring System for Laparoscopic Operations the procedures were graded based on procedural difficulty as simple (n=27; 12.9%), difficult (n=172; 82.8%), and highly difficult (n=9; 4.3%). Complications were observed in 13 (6.3%) interventions. One of these occurred during very hard and 14 during difficult procedures. According to Clavien-Dindo Classification; Grades 1, 2, and 3 A complications developed in 3 (1.4%), 9 (4.3%), and 1(0.5%) patient, respectively. CONCLUSION: Laparoscopic surgery is an efficient procedure in well-chosen patients for renal and adrenal diseases with low complication rates.

13.
Ren Fail ; 38(4): 503-7, 2016.
Article in English | MEDLINE | ID: mdl-26895083

ABSTRACT

OBJECTIVE: To assess the efficacy and safety of Retrograde Intrarenal Surgery to treat renal stones in patients with different American Society of Anesthesia (ASA) physical status. MATERIAL AND METHODS: We performed a retrospective analysis of 150 patients who underwent Retrograde Intrarenal Surgery for renal stone between October 2013 and December 2014. Patients were categorized into three groups according to their ASA physical status: ASA Class 1 (Group 1, n = 23), ASA Class 2 (Group 2, n = 113) and ASA Class 3 (Group 3, n = 14). We documented and stratified the per-operative and postoperative complications according to modified Satava Classification System and Clavien-Dindo Classification. RESULTS: The mean age of the patients was 44 years. The total stone-free rate was 81.2%. According to the groups, the stone-free rate was 75% in Group 1, 82.5% in Group 2, and 83.3% in Group 3 (p = 0.340). Per-operative and postoperative complications were recorded in 12% (n = 18) and 5.3% (n = 8) of the patients. We did not find significant difference in terms of per-operative and postoperative complication rates among patients with different ASA physical status (p(per-operative) = 0.392 and p(postoperative) = 0.136). CONCLUSIONS: Retrograde Intrarenal Surgery is an effective and safe surgery with high stone-free rates and low morbidity in patients with different ASA physical status.


Subject(s)
Anesthesia , Kidney Calculi/surgery , Kidney/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Anesthesiology , Female , Health Status , Humans , Male , Middle Aged , Patients/classification , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Retrospective Studies , Societies, Medical , United States , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/methods , Young Adult
14.
Arch Ital Urol Androl ; 88(4): 255-257, 2016 Dec 30.
Article in English | MEDLINE | ID: mdl-28073187

ABSTRACT

OBJECTIVES: In the current study, we present our pure laparoscopic heminephrectomy experience in 13 patients with horseshoe kidney (HK). MATERIAL AND METHODS: A total of 13 patients with HK underwent pure laparoscopic heminephrectomy (Transperitoneal= 7, Retroperitoneal = 6) due to benign and malign renal conditions (non-functional hydronephrotic and/or infected kidney = 12, kidney mass = 1). RESULTS: The mean age of the patients was 45.8 years. The mean operating time was 140 minutes, and estimated blood loss was 131 ml. The mean hospital stay was 2.3 days. Division of istmus was performed with stapler in 5 patients, ultrasonic scalpel in 3, 15 mm Hem-o-lok clip in 3, 10 mm LigaSure vessel seal system in one and endoscopic suture by 0 polyglactin in one patient without bleeding. Twelve patients underwent pure laparoscopic heminephrectomy due to nonfunctional hydronephrotic and or infected kidney. One patient underwent transperitoneal laparoscopic right heminephrectomy due to kidney mass. According to modifies Clavien classification, Grade I complication (wound infection) occurred in one patient (7.7%) who underwent heminephrectomy due to non-functional kidney. CONCLUSIONS: Laparoscopic heminephrectomy seems to be technically feasible and safe for benign and malignant diseases in patients with HK.


Subject(s)
Fused Kidney/complications , Kidney Diseases/complications , Kidney Diseases/surgery , Kidney Neoplasms/complications , Kidney Neoplasms/surgery , Laparoscopy , Nephrectomy/methods , Adult , Aged , Female , Humans , Male , Middle Aged
15.
Urology ; 86(3): 439-44, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26142716

ABSTRACT

OBJECTIVE: To investigate the relationship between bladder wall thickness (BWT) and uroflowmetric parameters and the International Prostate Symptoms Score (IPSS) in patients with lower urinary tract symptoms (LUTS). PATIENTS AND METHODS: A total of 236 male patients who had LUTS-related benign prostatic enlargement with serum prostate-specific antigen level ≤4 ng/mL were included in this study. Age and duration of LUTS and IPSS were recorded. BWT was measured using 7.5 mHz suprapubic ultrasonography before uroflowmetry and postvoid residual (PVR) was calculated thereafter. The relationship between BWT and poor indicators for bladder outlet obstruction (BOO) (IPSS >19, Qmax <15 mL/min, PVR >100 cm(3)) was investigated. RESULTS: The mean age was 62.5 ± 8.1 (39-77) years and the mean BWT was 3.8 ± 1.5 (1.4-8.7) mm. The mean IPSS, Qmax, PVR, and duration of LUTS were 17.7, 13.7 mL/min, 89.9, and 46.5 months, respectively. A positive correlation was found between BWT and IPSS, PVR and duration of LUTS, whereas a negative correlation was found between BWT and Qmax (P <.001). BWT increased when number of BOO parameters increased. BWT was 2.9 in patients without BOO parameters whereas BWT was 3.5, 4.1, and 4.5 mm in patients with any one, any two, and all parameters of BOO, respectively. CONCLUSION: BWT increased when number of BOO parameters increased. We believe that measurement of BWT is an easy, quick, and repeatable test to predict BOO severity.


Subject(s)
Lower Urinary Tract Symptoms/etiology , Urinary Bladder Neck Obstruction/diagnosis , Urinary Bladder/pathology , Adult , Aged , Endosonography , Humans , Lower Urinary Tract Symptoms/pathology , Lower Urinary Tract Symptoms/physiopathology , Male , Middle Aged , Sensitivity and Specificity , Urinary Bladder Neck Obstruction/complications , Urinary Bladder Neck Obstruction/physiopathology , Urodynamics/physiology
16.
Ulus Travma Acil Cerrahi Derg ; 20(6): 427-31, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25541922

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the success of penile fasciocutaneous flap urethroplasty in the treatment of long segment urethral stricture. METHODS: In this study, seventeen patients with long segment urethral stricture were included. In regard to the length of the narrow segment, vertical or circular penile skin fasciocutaneous flap was anastomosed on 18 F urethral catheter. In the first week and 6th month after removal of the urethral catheter, patients were controlled by uroflowmetry and postvoiding residual urine volume measurement by ultrasound. RESULTS: The mean age of the patients was 52 (range: 17 to 67 years). The mean follow up-time was 60 months (range: 12-96 months). Mean length of stricture was 105 mm (range: 40-150 mm). Vertical and circular penile fasciocutaneous flaps were used in four and 13 patients, respectively. Maximum urine flow rate and postvoiding residual urine assessment in the first week after removal of the urethral catheter were 19.1 ml/s (range: 9 to 31 ml/s) and 12.9 cm3 (range: 0 to 40 cm3), respectively. Same parameters in the postoperative 6th month were 17.4 ml/s (range; 8 to 25 ml/s) and 15.2 cm3 (range; 0 to 40 cm3), respectively. CONCLUSION: Our long term results revealed that penile fasciocutaneous flap urethroplasty method seemed to be a reasonable treatment option in the treatment of long segment urethral stricture.


Subject(s)
Penis/surgery , Surgical Flaps , Urethral Stricture/surgery , Adolescent , Adult , Aged , Humans , Male , Middle Aged , Treatment Outcome , Urologic Surgical Procedures, Male/methods , Young Adult
17.
Scand J Urol ; 48(4): 393-9, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24521184

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate effective factors in the survival of patients with Fournier's gangrene (FG) and compare three different validated scoring systems for outcome prediction: Fournier's Gangrene Severity Index (FGSI), Uludag Fournier's Gangrene Severity Index (UFGSI) and age-adjusted Charlson Comorbidity Index (ACCI). MATERIAL AND METHODS: Fifty men who underwent surgery for FG between July 2005 and August 2012 were included in the study. Data were collected on medical history, symptoms, physical examination findings, vital signs, admission and final laboratory tests, timing and extent of surgical debridement, and antibiotic treatment used. The FGSI, UFGSI and ACCI were evaluated stratified by survival. Admission and final parameters were measured using the Mann-Whitney test. RESULTS: The results were evaluated for two groups: survivors (n = 43) and non-survivors (n = 7). Survivors were younger than non-survivors (median age 58 vs 68.5 years, p = 0.017). The median extent of body surface area involved in the necrotizing process in patients who survived and did not survive was 2.3% and 4.8%, respectively (p = 0.04). No significant differences in laboratory parameters were found between survivors and non-survivors at the time of admission, except for haemoglobin, haematocrit, serum urea and albumin levels. Only UFGSI, but not FGSI or ACCI, had any meaning or predictive value in disease severity or patients' survival. CONCLUSION: Only the UFGSI score could predict the disease severity and the patients' survival. The findings did not support previous findings that an UFGSI threshold of 9 is a predictor of mortality during initial evaluation.


Subject(s)
Fournier Gangrene/diagnosis , Fournier Gangrene/surgery , Male Urogenital Diseases/diagnosis , Male Urogenital Diseases/surgery , Severity of Illness Index , Adult , Aged , Fournier Gangrene/mortality , Hematocrit , Humans , Male , Male Urogenital Diseases/mortality , Middle Aged , Predictive Value of Tests , Prognosis , Reproducibility of Results , Retrospective Studies , Serum Albumin/metabolism , Survival Rate , Treatment Outcome , Urea/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...